Company page

Cynata Therapeutics Limited

Cynata Therapeutics Limited, trading under the ticker CYP, is a public company based in Australia with a market capitalization of approximately AUD 44.36 million. The company focuses on developing innovative cell therapies, leveraging its proprietary Cymerus technology platform. Cynata aims to address unmet medical needs through its research and development efforts in the field of regenerative medicine.